Potential Mechanisms Responsible for Zymosan-Associated Endothelial Injury in Rats.

XM Deng,A Lasson,XD Wang,P Haraldsen,R Andersson
DOI: https://doi.org/10.1080/110241599750006758
1999-01-01
The European Journal of Surgery
Abstract:Objective: To assess alterations in endothelial barrier integrity and potential factors involved in zymosan-associated endothelial injury.Design: Experimental study.Setting: University hospital, Sweden.Animals: 42 adult male Sprague-Dawley rats.Interventions: One hour before an intraperitoneal injection of paraffin or zymosan (0.25 mg/g body weight), 1.0 ml of a solution of saline, N-acetyl-L-cysteine, dimethyl sulphoxide, indomethacin, verapamil, or allopurinol was given intravenously.Main outcome measures: Measurement of tissue water content, tissue intravascular plasma volume, interstitial fluid volume, and extravascular I-125-labelled human serum albumin distribution as well as plasma concentrations of albumin, alpha(1)-macroglobulin, alpha(2)-antiplasmin, and antithrombin III, 24 hours after the intraperitoneal injection.Results: Endothelial permeability significantly increased in abdominal organs and the gastrointestinal tract, and plasma antiplasmin concentrations decreased. Pretreatment with N-acetyl-L-cysteine, dimethyl sulphoxide, or indomethacin protected against zymosan-induced endothelial barrier injury and the decline in protease inhibitors in plasma to varying degrees, while pretreatment with verapamil or allopurinol had a limited effect.Conclusion: Oxygen free radicals, prostaglandin, and proteases may have roles in the pathogenesis of zymosan-induced endothelial barrier injuries, implying that several mediators probably are interacting.
What problem does this paper attempt to address?